Original article published by MedCity News on July 11, 2024
Naomi Fried identifies three major areas where pharma faces challenges and digital innovations show promise in developing new cancer drugs and treating patients with cancer. These include: (1) clinical trial design, (2) patient identification, and (3) patient engagement. This article discusses each challenge in detail and concludes with digital innovations that are addressing each of these pain points.
You can read the full article here .
Published
July 18, 2024
